8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 23, 2018

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

  (Commission File No.)  

(IRS Employer

Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

At the close of business on March 12, 2018, the record date of the Annual Meeting, the Company had 625 shares of Class B-1 common stock issued and outstanding. The holders of a total of 216 shares of Class B-1 shares were present at the adjournment of the Annual Meeting held on May 23, 2018, either in person or by proxy, which total constituted approximately 35% of the issued and outstanding shares on the record date for the Annual Meeting.

The results of the Class B-1 proposals are as follows:

 

1. The election of three Class B-1 Directors to serve until 2019 from a slate of three nominees (the nominees in bold were elected by the Class B-1 shareholders):

 

Name

   Votes For    Votes Against    Abstentions

Jeffrey M. Bernacchi

   176    8    32

Gedon Hertshten

   169    8    33

William W. Hobert

   160    10    46

 

2. The election of five members of the Class B-1 Nominating Committee to serve until 2019 from a slate of ten nominees (the nominees in bold were elected by the Class B-1 shareholders):

 

Name

   Votes For    Votes Against    Abstentions

Thomas A. Bentley

   96    16    89

Bradley S. Glass

   87    13    103

Joseph H. Gressel

   87    15    101

Mark S. Kobilca

   67    20    116

Gary T. Lark

   66    19    117

W. Winifred (Fred) Moore II

   75    22    106

William L. Polovin

   35    28    139

James V. Sauter

   30    27    143

Michael J. Small

   44    29    128

Michael G. Sundermeier

   32    26    142


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CME Group Inc.
    Registrant
Date: May 24, 2018     By:   /s/ Kathleen M. Cronin
    Name:   Kathleen M. Cronin
    Title:   Senior Managing Director, General Counsel and Corporate Secretary